A collection of over forty studies presented at the American Society of Clinical Oncology last month all point to a potential medical miracle: that GLP-1 drugs like Ozempic and Wegovy appear to be protecting patients against cancer. 

While most of the cancer-preventing benefits seem to come from the drugs reducing obesity — a risk factor for over a dozen forms of cancer — the findings also suggested that the drugs have anti-inflammatory effects that can stymy cancer development and even suppress tumors. Add it all up, and it could be a big deal for public health.